Task: Answer the following question about the molecule with SMILES Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Answer: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12
Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12
6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-9H-purine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.